Abstract
Purpose
The aim of this study was to evaluate characteristics of childhood glioblastoma multiforme, effectiveness of treatment modalities, and detect factors related to outcome.
Methods
A detailed analysis was performed on a series of 15 patients treated between 2000 and 2013, based on their clinical, radiologic, pathologic, treatment, and follow-up data.
Results
Median survival time of children with glioblastoma was 13.5 months. One- and 2-year overall survival probabilities were 66.7 and 20 %, respectively. There were no significant differences in survival based on patients’ gender, age, disease presentation with or without epileptic seizures, signs/symptoms of increased intracranial pressure, or tumor location. The presence of neurological deficit initially, as well as prior to radiotherapy, which was quantified by neurologic function score (NFS), had an impact on overall survival. Children with NFS 0 lived longer compared to others (p = 0.001). Survival of children that underwent gross total resection was longer than that of children that underwent subtotal resection (p = 0.030). Mean survival time of children with gross total resection was 73.5 months, compared to 13 months in children with subtotal resection. There was no significant correlation between outcome and type of radiotherapy. In four patients with gigantocellular glioblastoma, we found no evidence of a better prognosis. Two long-term survivors were recorded. Both of them underwent gross total resection and were assigned a NFS 0.
Conclusions
Gross total resection is essential for longer overall survival among pediatric patients with glioblastoma and offers a possibility for long-term survival. Severity of neurologic symptoms quantified by NFS can be considered as a potential predictor of outcome.
Similar content being viewed by others
References
Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(suppl 5):1–57. doi:10.1093/neuonc/nou223
Mahvash M, Hugo H-H, Maslehaty H, Mehdorn HM, Stark AM (2011) Glioblastoma multiforme in children: report of 13 cases and review of the literature. Pediatr Neurol 45:178–180. doi:10.1016/j.pediatrneurol.2011.05.004
Sánchez-Herrera F, Castro-Sierra E, Gordillo-Domínguez LF et al (2009) Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez. Childs Nerv Syst 25:551–557. doi:10.1007/s00381-008-0780-8
Das KK, Mehrotra A, Nair AP et al (2012) Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome. Childs Nerv Syst 28:2055–2062. doi:10.1007/s00381-012-1890-x
Perkins SM, Rubin JB, Leonard JR et al (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80:1117–1121. doi:10.1016/j.ijrobp.2010.03.013
Song KS, Phi JH, Cho B-K et al (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6:145–149. doi:10.3171/2010.5.PEDS09558
MacDonald TJ, Aguilera D, Kramm CM (2011) Treatment of high-grade glioma in children and adolescents. Neuro Oncol 13:1049–58. doi:10.1093/neuonc/nor092
Yang T, Temkin N, Barber J et al (2013) Gross total resection correlates with long-term survival in pediatric patients with glioblastoma. World Neurosurg 79:537–544. doi:10.1016/j.wneu.2012.09.015
Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM (2009) Pediatric giant cell glioblastoma: new insights into a rare tumor entity. Neuro Oncol 11:323–329. doi:10.1215/15228517-2008-099
Nikitović M, Bokun J, Paripović L, Golubičić I, Grujičić D, Sopta J (2013) Bone metastases in medulloblastoma—single institution experience. Pediatr Hematol Oncol 30:80–91. doi:10.3109/08880018.2012.752888
Nikitović M, Golubičić I, Pekmezović T, Grujičić D, Plešinac-Karapandžić V (2011) Outcome of childhood brain tumors in Serbia. J BUON 16:290–296
Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N et al (2002) Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94:264–71. doi:10.1002/cncr.10114
Suri V, Das P, Pathak P et al (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11:274–280. doi:10.1215/15228517-2008-092
Reddy GD, Sen AN, Patel AJ, Bollo RJ, Jea A (2013) Glioblastoma of the cerebellum in children: report of five cases and review of the literature. Childs Nerv Syst 29:821–832. doi:10.1007/s00381-012-1996-1
Vern-Gross TZ, Broniscer A, Schreiber J, Xiong X, Merchant TE (2012) Prospective evaluation of local control and late effects of image guided radiation therapy in childhood high-grade glioma. Int J Radiat Oncol Biol Phys 84:S67. doi:10.1093/neuonc/nou101
Jung TY, Kim CY, Kim DS et al (2012) Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study. Childs Nerv Syst 28:1033–1039. doi:10.1007/s00381-012-1786-9
Duffner PK, Horowitz ME, Krischer JP et al (1999) The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol 1:152–161
Broniscer A, Chintagumpala M, Fouladi M et al (2006) Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 76:313–319. doi:10.1007/s11060-005-7409-5
Lashford LS, Thiesse P, Jouvet A et al (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684–4691
Finlay JL, Boyett JM, Yates AJ et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children’s Cancer Group. J Clin Oncol 13:112–123
Cage TA, Mueller S, Haas-Kogan D, Gupta N (2012) High-grade gliomas in children. Neurosurg Clin N Am 23:515–23. doi:10.1016/j.nec.2012.04.007
Sabel M, Reifenberger J, Weber RG, Reifenberger G, Schmitt HP (2001) Long-term survival of a patient with giant cell glioblastoma. Case report. J Neurosurg 94:605–611. doi:10.1159/000228545
Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C (2006) Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst 22:314–319. doi:10.1007/s00381-005-1239-9
Prada I, Cordobés F, Azorín D, Contra T, Colmenero I, Glez-Mediero I (2006) Pediatric giant cell glioblastoma: a case report and review of the literature. Childs Nerv Syst 22:285–289. doi:10.1007/s00381-005-1178-5
Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D et al (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer 51:977–983
Jain S, Sharma V, Sinha V, Sundar V, Bhasme V, Goel R (2012) Giant cell glioblastoma in a child: a rare case report. Asian J Neurosurg 7:144. doi:10.4103/1793-5482.103723
Khalatbari MR, Hamidi M, Moharamzad Y (2011) Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature. Childs Nerv Syst 27:1347–1352. doi:10.1007/s00381-011-1492-z
Sonoda Y, Kumabe T, Watanabe M et al (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 151:1349–1358. doi:10.1007/s00701-009-0387-1
Srivastava A, Jain A, Jha P, Suri V, Sharma MC, Mallick S, Puri T, Gupta DK, Gupta A, Sarkar C (2010) MGMT gene promoter methylation in pediatric glioblastomas. Childs Nerv Syst 26:1613–8. doi:10.1007/s00381-010-1214-y
Jha P, Suri V, Singh G et al (2011) Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults. Diagn Mol Pathol 20:225–232. doi:10.1097/PDM.0b013e31821c30bc
Sturm D, Bender S, Jones DTW et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107. doi:10.1038/nrc3655
Ezaki T, Sasaki H, Hirose Y, Miwa T, Yoshida K, Kawase T (2011) Molecular characteristics of pediatric non-ependymal, non-pilocytic gliomas associated with resistance to temozolomide. Mol Med Rep 4:1101–1105. doi:10.3892/mmr.2011.573
Buttarelli FR, Massimino M, Antonelli M et al (2010) Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas. Childs Nerv Syst 26:1051–1056. doi:10.1007/s00381-010-1191-1
Lee JY, Park CK, Park SH, Wang KC, Cho BK, Kim SK (2011) MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA. Childs Nerv Syst 27:1877–1883. doi:10.1007/s00381-011-1525-7
Acknowledgments
The authors would like to thank Ana Ivkovic, senior librarian at the Institute for Oncology and Radiology of Serbia, Belgrade, for her assistance with the preparation of this manuscript. We are also grateful to Mina Nikitovic, linguist, for her help with the linguistic aspects of this manuscript. Tatjana Pekmezovic was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant no. 175087).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nikitović, M., Stanić, D., Pekmezović, T. et al. Pediatric glioblastoma: a single institution experience. Childs Nerv Syst 32, 97–103 (2016). https://doi.org/10.1007/s00381-015-2945-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2945-6